EXH5:XETRA:XETRA-iShares STOXX Europe 600 Insurance UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 38.385

Change

0.00 (0.00)%

Market Cap

USD 0.30B

Volume

3.72K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.75 (+1.44%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.25 (+1.48%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.37 (+1.36%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.38 (+1.35%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.34 (+1.38%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+2.74 (+1.90%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.84 (+1.80%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.74 (+1.44%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.59 (+0.61%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.46 (+0.63%)

USD 80.38B

ETFs Containing EXH5:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.49% 72% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.49% 71% C- 71% C-
Trailing 12 Months  
Capital Gain 19.32% 72% C 72% C
Dividend Return 0.43% 12% F 7% C-
Total Return 19.75% 72% C 72% C
Trailing 5 Years  
Capital Gain 20.46% 45% F 49% F
Dividend Return 12.23% 91% A- 63% D
Total Return 32.69% 52% F 54% F
Average Annual (5 Year Horizon)  
Capital Gain 6.68% 61% D- 59% D-
Dividend Return 8.96% 69% C- 66% D+
Total Return N/A 95% A 41% F
Risk Return Profile  
Volatility (Standard Deviation) 15.47% 34% F 46% F
Risk Adjusted Return 57.88% 64% D 67% D+
Market Capitalization 0.30B 56% F 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.